PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,2-dimethyl-5-(1-methylpropenyl)tetrahydrofuran | 231-028-3 | 7416-35-5 | - | - | - | - | 1 | - | - | - | - | Details |
| N,N'-(methylenedi-p-phenylene)bis(aziridine-1-carboxamide) | 231-034-6 | 7417-99-4 | - | - | 1 | - | 2 | - | - | - | - | Details |
| Dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-) | 277-749-7 | 74181-84-3 | - | - | 2 | - | 1 | - | - | - | - | Details |
| D-Glucopyranose, oligomeric, C10-16-alkyl glycosides, 2-hydroxy-3-sulfopropyl ethers, sodium salts | 664-492-4 | 742087-49-6 | - | - | 2 | - | - | - | - | - | - | Details |
| 2-Methyl-2-nitropropane-15N | 685-812-9 | 74228-29-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-ethylhexyl hydrogen maleate | 231-048-2 | 7423-42-9 | - | - | 1 | - | - | - | - | - | - | Details |
| Lanthanum | 231-099-0 | 7439-91-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Lead | 231-100-4 | 7439-92-1 | - | - | - | - | 1 | 2 | 1 | 1 | - | Details |
| Lithium | 231-102-5 | 7439-93-2 | - | - | - | - | 2 | - | - | - | - | Details |
| Manganese | 231-105-1 | 7439-96-5 | - | - | - | - | 2 | - | - | - | - | Details |